Approval grants Gelteq fast track pathway for drug and entrance into the animal pharmaceuticals spaceNEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical ...
Australia wasn’t a great invasion; it was a great escape. Yet, again this week, we have a poorly educated Chinese-owned company which bought 200 Australian pubs and bars and banned them from ...